Skip to main navigation

Skip links

  • Skip to content
  • Skip to footer

Akari TX

Main navigation

Menu
  • Home
  • About
    • Company Overview
    • Management
    • Board of Directors
    • CEO CORNER
    • Scientific Advisory Board
  • Areas of Focus
    • Pipeline
    • Posters & Publications
  • Investor Relations
    • Overview
    • Corporate Governance
      • Governance Overview
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
      • Annual Reports
    • News & Presentations
      • Press Releases
      • Presentations
    • Analyst Coverage
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Email Alerts
  • Press
    • Press Releases
  • Contact Us

PRE 14A

SEC Filing Details

Document Details

Form
PRE 14A
Filing Date
May 22, 2026
Document Date
May 22, 2026
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
Akari Therapeutics
Issuer
AKARI THERAPEUTICS PLC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL DEFINITION FILE
EX-101.LAB - XBRL LABEL FILE
EX-101.PRE - XBRL PRESENTATION FILE
XML - XBRL INSTANCE DOCUMENT
Tools
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact Us

Footer

Follow Us

Terms of Use
Privacy Statement
Contact Us

Akari TX

Copyright © 2026 Akari Therapeutics Plc. All rights reserved.